IAS Inflammation Academy

Overview

The International Atherosclerosis Society Inflammation Academy aims to identify and develop promising early career researchers and physicians who have the capacity to become the next generation of key opinion leaders on the topic of inflammation in cardiometabolic disease. 

The Inflammation Academy has four core learning objectives:

  1. To become acquainted with the latest thinking, data, and research regarding inflammation as a driver of cardiovascular disease  
  2. To understand methods for assessing inflammation in clinical practice 
  3. To learn the current, state of the art anti-inflammatory interventions, including lifestyle and medical therapy 
  4. To consider barriers for implementation of inflammation science in the clinical practice of cardiovascular medicine and approaches to addressing gaps 

The vision for the Inflammation Academy and how the program aims to equip leaders of the future with essential skills and build on advances in inflammation research was captured by Judith Ozkan in a piece published in the European Heart Journal. 

Learn more about the 2026-2027 cohort and their upcoming program experience.

2026-2027 Flagship Experience

The 2026-2027 Inflammation Academy is being led by Peter Libby, MD, along with international faculty Cristina Izar, MD, PhD; Isabel Gonçalves, MD, PhD; Samia Mora, MD, MHS; and Wolfgang Koenig, MD.

The year-long flagship experience has three components: 

  1. In-Person Session: Fellows came together for a day-long program in Munich, Germany on August 27, 2026. Fellows will receive face-to-face instruction from the international faculty, get to know each other, and network with some fellows from the 2025-2026 cohort. 
    View the agenda
  2. Webinar Series: The Inflammation Academy will host a series of live, interactive webinars focusing on current issues or controversies related to inflammation. The webinar topics will be determined by using input from the fellows and each session of the webinar series will be developed by a subgroup of fellows, mentored by a faculty member. The series is designed to further the mentor-mentee relationships and provide participants with an opportunity to delve deeper into the content, strengthen their working relationships with other fellows, and to present to IAS’ global audience. 
  3. Thought Leadership Development: This workstream is designed to build fellows’ confidence and understanding of thought leadership, and to upskill fellows in communicating to non-clinician audiences, from policymakers to patient communities. This component begins with a two-hour virtual interactive training course and fellows are supported in writing a long-form blog.

This activity is supported by contributions from Novo and Lilly. All program content remains fully under the control of IAS.

Learn more about the 2025-2026 Flagship Experience

Meet the Fellows & Faculty

View the Program and Watch Recordings of the In-Person Session

Watch the Webinar Recordings

Read the Thought Leadership Blogs

This activity is supported by contributions from Novo Nordisk. All program content remains fully under the control of IAS.

Promoting the scientific understanding of atherosclerosis

Newsletters

Stay in touch with IAS